Skip to main content
. 2009 Jun;127(2):196–205. doi: 10.1111/j.1365-2567.2008.02937.x

Figure 2.

Figure 2

The percentages of different regulatory T-cell (Treg) subsets and effector T cells (Teffs) in patients with systemic lupus erythematosus (SLE) and in healthy controls. The results are shown as percentages of CD25high Tregs, CD25low Tregs, CD25 Tregs and Teffs in normal controls (n = 36), in patients with inactive SLE (n = 29), in patients with active SLE (n = 58) and in patients with ankylosing spondylitis (AS) (n = 23). Symbols represent the frequencies of Treg subsets and Teffs in individual samples. The line within the vertical points marks the mean for each group. A P-value of<0·05 was considered as significant following analysis of the results using a general linear model adjusted for gender and age. See Fig. 1 for other definitions.